2. Summary of Significant Accounting Policies: Research and Development Costs (Policies)
|12 Months Ended|
Sep. 30, 2016
|Research and Development Costs||
Research and Development Costs
All expenditures for research and development are charged to expense as incurred. Research and development expenses for fiscal years 2016 and 2015 were $248,441 and $106,526, respectively. The Company expects to continue investing in research and development as it develops new products and platforms for Chronic Illness Monitoring and as funds become available.
Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.
Reference 1: http://www.xbrl.org/2003/role/presentationRef